Most owners I talk to have the same first sentence: "I'm not ready to sell." And most of the time, they're right — but they're answering the wrong question. The question isn't whether to sell your company. It's whether all of your net worth should stay locked inside it while you keep running it.

A minority sale — 10 to 20% of your equity — exists for exactly this situation. Done properly, it puts real money in your pocket, keeps you unambiguously in charge, and gives you a partner with skin in the game. Done badly, it invites a stranger into your cap table with rights you didn't read closely enough. Here's how to tell the difference.

What you're actually selling

At 10–20%, you are not selling control. You're selling a slice of future profits and, with the right buyer, purchasing three things at once:

  • Liquidity — cash at close, at a market multiple, without debt on the business or on you personally.
  • A sounding board with consequences — an investor who wins only if you win, sitting in a quarterly review with real opinions and real networks.
  • A rehearsal for the eventual exit — you learn how diligence works, what your numbers look like normalized, and what buyers value, years before it's all-or-nothing.

What a fair minority deal looks like

In the lower-middle market, minority stakes trade around market EBITDA multiples — typically 2–4× for the stake, adjusted for growth, customer concentration, and how dependent the business is on you. Beyond price, the terms are where control lives or dies. A seller-friendly structure looks like this:

  • Board observer, not board control. The investor watches and advises; you decide. Veto rights limited to genuinely structural events — issuing new shares, a merger — not hiring, pricing, or strategy.
  • Reporting you should be doing anyway. Quarterly financials and a KPI dashboard. If an investor demands weekly control at 15%, walk away.
  • Fees tied to outcomes, not access. If there are management or advisory fees, they should activate on performance triggers you agreed to in writing — not on day one.
The test of a minority partner is simple: if you deleted every email from them for a quarter, would the business run exactly as you intended? At 10–20%, the answer should be yes.

The three traps

Trap one: the ratchet. Some minority investors accept a small stake but attach preferences that guarantee them a return before you see a dollar at exit. Ask directly: "Is this common equity, pari passu with mine?" If the answer takes more than one sentence, it isn't.

Trap two: the creeping board. A single observer seat that becomes a full seat at the first missed quarter, then two seats. Rights should be fixed at signing and change only if you choose to sell more later.

Trap three: the strategic with an agenda. A competitor or supplier buying 15% is rarely buying 15%. They're buying information. Take financial capital from financial partners.

When a minority sale is the wrong move

Honesty cuts both ways. If your revenue is declining, if one customer is half your book, or if the business can't run ninety days without you, a minority stake will price poorly — and the discount will annoy you into a worse decision later. Fix those three things first; each of them moves your multiple more than any negotiation tactic ever will.

And if what you actually want is to stop working weekends, be honest about that too — that's not a 15% conversation, and a good buyer will tell you so in the first meeting rather than the eleventh.

Where NeoNox fits

Our Tier 1 exists precisely for this playbook: 10–20% of your equity, a board observer with quarterly reviews, guidance that costs nothing until agreed performance triggers are met, and terms published before you sign. You stay the owner-operator. Nothing about your Monday changes — except the part where your family's net worth no longer rides entirely on it.